MedImpact’s novel program harnesses pharmacogenomics to deliver actionable results to prescribers. It does this by screening for genetic interactions with more than 240 commonly prescribed medications and notifies prescribers when a potential gene-drug interaction exists.
The PBM MedImpact Is Proactively Personalizing Medicine
